We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nanoparticle-Delivered Drug Cocktail Blocks Spread of Malignant Melanoma Through the Lymph System

By LabMedica International staff writers
Posted on 21 Dec 2015
Print article
Image: Ball-and-stick model of the docetaxel molecule (Photo courtesy of Wikimedia Commons).
Image: Ball-and-stick model of the docetaxel molecule (Photo courtesy of Wikimedia Commons).
A nanoparticle-based delivery system was used to transport a cocktail of three anticancer drugs to the lymph nodes, which prevented the spread of malignant melanoma in two mouse models.

Metastatic melanoma has a high mortality rate due to lymphatic progression of the disease. Current treatment is surgery followed by radiation and intravenous chemotherapy. However, drawbacks for current chemotherapeutics lie in the fact that the tumors develop resistance, and the drugs do not achieve therapeutic concentrations in the lymphatic system.

To correct this problem, investigators at Oregon State University (Corvallis, USA) proposed that a three-drug nanoscale delivery system, tailored for lymphatic uptake and administered subcutaneously, would have decreased drug resistance and therefore offer better therapeutic outcomes.

To this end, the investigators prepared and characterized nanoparticles (NPs) from polyethyleneglycol-block-poly(epsilon-caprolactone) (PEG–PCL) polymer with different charge distributions that were created by modifying the ratio of anionic and neutral end groups on the PEG block. The nanoparticles were loaded with a cocktail of drugs that included docetaxel (a clinically well-established anti-mitotic chemotherapy medication that works by interfering with cell division), everolimus (an immunosuppressant used to prevent rejection of organ transplants and for treatment of renal cell cancer and other tumors), and LY294002 (a morpholine-containing chemical compound that is a potent inhibitor of numerous proteins, and a strong inhibitor of phosphoinositide 3-kinases (PI3Ks)).

The NPs were similarly sized (approximately 48 nanometers), with neutral, partially charged, or fully charged surfaces. The NPs could be loaded with about two milligram per milliliter of each drug and were stable for 24 hours.

The NPs were assessed for safety and efficacy in two transgenic metastatic melanoma mouse models. Results published in the November 11, 2015, online edition of the Journal of Controlled Release revealed that all the NPs were safe in both models based on general appearance, weight changes, death, and blood biochemical analyses. The partially charged NPs were most effective in decreasing the number of melanocytes at both the proximal (sentinel) lymph node (LN) and the distal LN from the injection site. The neutral NPs were efficacious at the proximal LN, while the fully charged NPs had no effect on either LNs. Thus, the NP surface charge and lymphatic efficacy were closely tied to each other, and the partially charged NPs had the highest potential in treating metastatic melanoma.

"Melanoma can be a very difficult cancer to treat because it often metastasizes and travels through the lymphatic system," said senior author Dr. Adam Alani, assistant professor of pharmacy at Oregon State University. "Melanoma has a high mortality rate because the lymph nodes tend to act as a haven for cancer cells, and allow them to resist treatment through chemotherapy."

Related Links:

Oregon State University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.